ROCKETDNA LTD. — Capital/Financing Update 2023

Dec 7, 2023

==> picture [601 x 87] intentionally omitted <==

ASX Announcement

Notice under Section 708A of the Corporations Act

8 December 2023 – RocketDNA Ltd (Issuer or Company) ( ASX: RKT ), hereby gives this notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (“ Act ”).

The Company has today issued 118,333,329 ordinary fully paid shares at an issue price of $0.009 (0.9 cents) per share ( Issued Shares ) in accordance with the terms of the placement announcement to the market on 4 December 2023.

In accordance with section 708A(5)(e) of the Act, the Company gives notice that:

1. the Issued Shares were issued without disclosure to investors under Part 6D.2 of the Act;

2. as at the date of this notice, the Company has complied with the provisions of Chapter 2M of the Act, as they apply to the Company and sections 674 and 674A of the Act; and

3. as at the date of this notice there is no information that is ‘excluded’ information within the meanings of section 708A(7) and 708A(8) of the Act, being information:

   • a) that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules;

   • b) that investors and their professional advisers would reasonably require for the purposes of making and informed assessment of:

     • i. the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

ii. the rights and liabilities attaching to the Securities.

This announcement has been authorised for release by the Board of RocketDNA Ltd.

Yours faithfully Stephen Buckley Company Secretary

==> picture [612 x 80] intentionally omitted <==